logo
Q&A: Familial and Genetic Risk in Ovarian Cancer

Q&A: Familial and Genetic Risk in Ovarian Cancer

Medscape7 days ago
Maurie Markman, MD
Malignant ovarian neoplasms are a significant cause of cancer mortality in women.[1] Important risk factors include age, family history of breast or ovarian cancer (OC), personal history of breast cancer, endometriosis, and pelvic inflammatory disease.[2] Maurie Markman, MD, is president of medicine & science at City of Hope, and he talked to Medscape about the clinical implications of familial and genetic risk in OC.
What is the importance of genetics in OC?
We know a lot about OC genetics compared to when I started in this area. This is a fascinating part of medical history from over 50 years ago when nobody talked about OC. Patients would tell you that a family member — their mother, sister, or grandmother — had died of something that involved the stomach area. Historically, however, if you went back, there was no way of knowing if it was OC or gastric cancer because gastric cancer was extremely common. Additionally, there was nothing you could do about genetic risk at the time, nor much appreciation of how substantial this risk really is. The cumulative OC risk to age 80 years for women with BRCA1 is 36%-53% and 11%-25% for BRCA2 carriers.[3]
What do we know about familial and genetic risk in OC?
All patients diagnosed with OC should receive germline genetic testing. This is a decade-old recommendation from the National Comprehensive Cancer Network, American Society of Clinical Oncology,[4] Society of Gynecologic Oncology,[5] and European Society for Medical Oncology[6] and it still isn't done. This recommendation is based not only on the increased risk for OC in patients with genetic mutations, including BRCA1 , BRCA2 , MLH1 , MSH2 , or MSH6 (the Lynch syndrome genes), but also due to its implications to patient management and risk-reduction strategies. There is evidence showing that most eligible patients are not offered genetic testing, and the main factors associated with this noncompliance are older age, ethnicity, and insurance coverage.[7] This is a real problem. All healthcare providers, not just gynecologic oncologists, should be aware of the importance of germline genetic testing.
Can you tell us more about the implications of genetic testing to patient management?
The first implication is to the patient diagnosed with OC. BRCA1 and BRCA2 are tumor-suppressor genes involved in DNA repair, and their loss may cause cancer or change its course. BRCA1/BRCA2 mutation is recognized as a genetic marker for targeted therapy. There is overwhelming evidence that poly(ADP-ribose) polymerase (PARP) inhibitors have incredible impact on overall survival in OC as first-line, second-line, or later maintenance therapy in patients with platinum-sensitive relapsed tumors.[8,9] The impact on survival is enormous. This is not a treatment decision up for debate, and you won't know which patient will benefit from PARP inhibitors unless you carry out genetic testing.
Beyond patient management, what is the impact of germline genetic testing?
Germline testing helps determine a person's genetic predisposition to OC which is different from somatic testing of cancerous cells.[10] The impact extends to the patient's family and their support system. Family members, both male and female, could be at risk for genetic discrimination, including problems with life and health insurance, relationships, and even employment based on cancer risk. Genetic counselors are fundamental to guide patients and healthcare providers to understand the risks associated with pathogenic mutations and to decide on risk-reduction options. Today, genetic testing is strongly recommended because there are risk-reduction strategies that outweigh these negative risks I just mentioned.[4,5,6]
When should genetic testing be offered to family members?
Personal circumstances and preferences, such as family planning and reproductive options, should guide discussions about screening recommendations. Genetic testing is recommended to individuals with significant family history of OC and those from populations with high pathologic variant carrier frequencies, including Ashkenazi Jews, for example.[4,5,6] For asymptomatic women without a known high-risk hereditary cancer syndrome, the US Preventive Services Task Force recommends no screening for OC.
What are the strategies for risk reduction?
The most effective approach to prevent ovarian and fallopian tube cancers is risk-reducing bilateral salpingo-oophorectomy.[11] Typically, it is recommended to patients with pathologic variants in BRCA1/2, BRIP1, RAD51C, RAD51D , or MLH1, MSH2 , and MSH6 . Surgery can reduce the risk for gynecologic tumors by 80%-90% and decrease the all-cause mortality by 77%. The timing of surgery is also influenced by the patient's age, desire for pregnancy, family history, and the consequences of premature menopause.
Can you tell us more about ongoing clinical trials about OC that could change clinical practice?
I can mention two different approaches that could change clinical practice: bilateral salpingectomy for OC prevention and antibody-drug conjugates (ADCs) for the treatment of patients with poor survival prospects. Based on a theory that most OCs originate in the fimbriated end of the fallopian tube and then spread to the ovary, the hypothesis is that surgical resection of the fallopian tubes in women with increased risk may prevent the development of epithelial OC and avoid premature menopause.[12] We still need to know more about surgery eligibility and long-term survival outcomes.
Very interesting. What are ADCs?
ADCs are targeted therapies consisting of monoclonal antibodies capable of delivering cytotoxic drugs, the payload, directly to the tumor site while reducing systemic exposure and toxicity. Ideally, the payload should be released in the intracellular space.[13] Currently, there are many clinical trials trying to identify suitable targets and clinically effective therapies that could increase overall survivor in patients with OC.[14]
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Can Metformin Prevent Severe Morning Sickness?
Can Metformin Prevent Severe Morning Sickness?

Medscape

time29 minutes ago

  • Medscape

Can Metformin Prevent Severe Morning Sickness?

TOPLINE: Daily metformin use in the month before pregnancy is associated with more than 70% reduction in risk for hyperemesis gravidarum in first pregnancies. The protective effect persists in second pregnancies with 82% lower risk, even after accounting for the high recurrence risk, while cannabis use and selective serotonin reuptake inhibitors increase risk. METHODOLOGY: Researchers analyzed data from 5414 participants who reported on daily medication and substance use in the month prior to pregnancy and level of nausea and vomiting during pregnancy. Participants were recruited through the Hyperemesis Gravidarum Education and Research Foundation social media sites from January 2023 to September 2024. Analysis included logistic regression to estimate crude and multivariate associations between use of 32 common substances and severe nausea and vomiting of pregnancy/hyperemesis gravidarum. Final multivariate models incorporated tobacco use and maternal age, while number and type of additional drugs used and race/ethnicity showed minimal influence. TAKEAWAY: Prepregnancy metformin use was associated with more than 70% reduction in risk for hyperemesis gravidarum (adjusted relative risk [aRR], 0.29; 95% CI, 0.12-0.71; P = .007). Tobacco use showed significant reduction in risk (aRR, 0.51; 95% CI, 0.30-0.86; P = .011), while selective serotonin reuptake inhibitors were linked to increased risk (aRR, 2.41; 95% CI, 1.33-4.38; P = .004). Metformin use before a second pregnancy was associated with 82% lower risk for severe nausea and vomiting/hyperemesis gravidarum (adjusted odds ratio [aOR], 0.18; 95% CI, 0.06-0.59; P = .005), even after adjusting for an 86% recurrence risk. Cannabis use (aOR, 3.48; 95% CI, 1.80-6.75; P < .001) and selective serotonin reuptake inhibitors (aOR, 1.84; 95% CI, 1.12-3.04; P = .016) before a second pregnancy were associated with increased risk. IN PRACTICE: 'Metformin, which is routinely used pre- and post-conception, may be a safe and affordable treatment to offer patients with a prior history of hyperemesis gravidarum to decrease the chance of recurrence. Clinical trials are warranted to investigate metformin use prior to pregnancy to lower hyperemesis gravidarum risk, thereby mitigating the associated adverse maternal and offspring outcomes,' wrote the authors of the study. SOURCE: The study was led by Neelu Sharma, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California in Los Angeles. It was published online in American Journal of Obstetrics and Gynecology. LIMITATIONS: The hyperemesis gravidarum-enriched approach to participant recruitment may have introduced selection bias, as individuals with multiple occurrences may have been more likely to participate. However, the authors noted that similar recurrence rates were reported in previous prospective studies. Additionally, the indication, timing, and dosage for each medication or substance was unknown. While conditions commonly treated with metformin like diabetes and polycystic ovary syndrome have been associated with increased risk for hyperemesis gravidarum, any confounding by indication would bias results upward rather than explain the observed inverse associations. DISCLOSURES: Marlena S. Fejzo disclosed being a consultant for NGM Biosciences, receiving stock and fee for service. The remaining coauthors reported having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Lonely at work? Emotional intelligence can help
Lonely at work? Emotional intelligence can help

Fast Company

time39 minutes ago

  • Fast Company

Lonely at work? Emotional intelligence can help

While remote work offers several benefits such as flexibility, working from home can also be lonely. In one survey almost a quarter (23%) of remote workers reported feeling lonely. Loneliness at work can result in decreased productivity, and feelings of dissatisfaction. Emotional intelligence can help us understand what to do to feel more connected at work. Here are four steps to take: Develop Self-Awareness Most of us experience periods of loneliness. Being self-aware allows us to better recognize when we are feeling lonely, link it to what is going on at the time, and come up with solutions. Even being able to express what we are feeling can help alleviate loneliness, as naming what we're feeling helps us to gain more control over our emotions. Consider journaling when you feel lonely to understand what you're feeling, as well as what situations cause these feelings. Discovering the circumstances that cause loneliness may help you avoid or alleviate loneliness in the future. Manage Emotions There are various methods for regulating and coping with our emotions, and one size does not fit all. Some methods that are known to work are deep breathing, mindfulness, walking in nature, or simply getting away momentarily from the setting we are in. I have found taking a short break from whatever is stressing me out and imagining a relaxed pleasurable experience helps me regulate my emotions. Experiment with different practices to learn what works for you. Increase Empathy If we are high in empathy, we will be more likely to reach out to others if we are experiencing feelings of loneliness. One way to increase empathy is to identify the emotions you hear someone bring up in conversations. For example: 'I hear you are feeling angry, sad, or afraid.' Chances are others share our feelings, and may be hesitant to reach out, unaware that others are struggling with the same problem. By increasing our empathy and reaching out, we form bonds, increase vulnerability, openness, and connection. Knowing that we are not alone in our situation and having people we can reach out to for support can go a long way in making us feel more connected. Build connections As humans we are hardwired to connect with others. This becomes even more important for remote workers. Creating opportunities to build connections is something that everyone needs to take ownership of, from leaders on down. Set aside some social time where everyone can share what is going on in their lives apart from work. If you have regular online meetings, take a few minutes to share something personal, such as challenges, struggles, and joys. If you have colleagues in the same city, try to get together in person on occasion. Encourage and support each other to come up with ideas on how to connect. Leadership could also host office lunches, where the company covers the cost of lunch and provides space for an informal online get-together. One of the ongoing topics could be how other people experience loneliness and what tools they use to work through it. Leaders can use their emotional intelligence to combat the loneliness associated with remote work. In my book Bigger Hearted: a Retired Pediatrician's Prescriptions for Living a Happier Life, I describe how the head of a local mental health center worked to alleviate loneliness on his team. He called each of them during their work hours, staying up late for several nights so he could talk to those who covered late-night emergencies. It may also help to s eek value and connection outside of work, whether through time with family and friends, hobbies, or volunteer work. Having something where you know you will be seen, heard, and supported can help alleviate loneliness and offer a bright spot in the day to look forward to.

How to trick your nervous system into calming down when you're stressed at work
How to trick your nervous system into calming down when you're stressed at work

Fast Company

time39 minutes ago

  • Fast Company

How to trick your nervous system into calming down when you're stressed at work

Understanding how your body works can be the key to reducing stress. For example, you're probably aware of your fight-or-flight response —the body's way of preparing itself when it believes it's being threatened. What happens is your sympathetic nervous system is activated, pumping adrenaline and glucocorticoid steroids into your system that give you hyper focus, energy and strength to handle the situation. Fight-or-flight was a survival mechanism during hunter-gatherer times, when the threat of wild animals was real. Today, however, it's often triggered by non-life-or-death events, such as the evening news, tight deadlines, or traffic. On the flipside of fight-or-flight is rest-and-digest. It's the body's way of rebalancing itself after the danger has passed. In this case, your parasympathetic nervous system is in charge, decreasing your heart rate and blood pressure and providing a sense of calm. Sometimes, though, the body has a hard time getting back into rest-and-digest. It stays in a state of stress and anxiety. When this happens, it's often due to your vagal tone, which is the activity in your vagus nerve, says Kevin Tracey, M.D., author of The Great Nerve: The New Science of the Vagus Nerve and How to Harness Its Healing..

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store